Abstract
Lu S, Cheng Y, Huang D, et al. Selpercatinib in Chinese patients with RET-fusion-positive non-small-cell lung cancer: updated efficacy and safety analysis from the LIBRETTO-321 phase II trial. Therapeutic Advances in Medical Oncology. 2025;17. doi:10.1177/17588359241307199
In the above referenced article, the below article title has been corrected. The correct title reads as:
Selpercatinib in Chinese patients with RET-fusion-positive non-small-cell lung cancer: updated efficacy and safety analysis from the LIBRETTO-321 phase II trial
The referenced article has been updated online.